YOU ARE HERE: Home > Guidelines and Clinical Policy > 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation ...

People who reported spending six or more hours on screens outside of school or work had worse blood pressure, cholesterol and body mass index (BMI) compared with those with more limited screen time, ...

A new ACC Expert Consensus Decision Pathway (ECDP) addressing "Optimization of Postpartum Care for Patients With and at Risk for Premature and Long-Term Cardiovascular (CV) Disease" provides ...

Pulmonary-artery denervation, in addition to guideline-directed medical therapy, resulted in fewer events of clinical worsening than medical therapy alone in patients with pulmonary hypertension ...

In IDEAL-AF, simultaneously published in JAMA, adjunctive low-voltage zone ablation following pulmonary vein isolation improved rhythm outcomes and health-related quality of life without increasing ...

The U.S. Food and Drug Administration (FDA) has approved the Sapien 3, Sapien 3 Ultra and Sapien 3 Ultra Resilia TAVR valves from Edwards Lifesciences to treat patients with asymptomatic severe aortic ...

The American Heart Association (AHA)'s new scientific statement advocates a more personalized approach to managing high blood pressure in patients who are hospitalized. By introducing revised ...

A nurse-led collaborative care model that integrated mobile health improved overall survival and days out of the hospital among patients with heart failure with reduced ejection fraction (HFrEF) in ...

The ACC, in partnership with the JF Maddox Foundation, kicked off the Rural Cardiovascular Health Initiative (RCHI) earlier this year. The 12-month pilot project taking place in Hobbs, NM, aims to ...

Patients with transthyretin amyloidosis with cardiomyopathy (ATTR-CM) who were treated with eplontersen, a once-monthly transthyretin gene silencer, experienced no significant difference in ...

About 50% of U.S. adults will develop high BP during their lifetime. High BP is the most prevalent and modifiable risk factor for cardiovascular disease and all-cause mortality. The overarching BP ...

A newly released ACC Expert Consensus Decision Pathway (ECDP) focused on the clinical assessment, management and trajectory of patients hospitalized with heart failure (HF) includes revisions to the ...